Global Health Limited has announced its quarterly earnings conference call to discuss the financial performance for the third quarter and nine-months ended December 31, 2025. The healthcare provider, operating under the Medanta brand, will host the call on February 5, 2026 at 2:00 PM IST.

Conference Call Details

The earnings call will be hosted by JM Financial and will provide investors and analysts with insights into the company's Q3FY26 financial results. The call has been scheduled in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Management Participation

The conference call will feature participation from Global Health Limited's senior management team, providing comprehensive coverage of the company's operational and financial performance.

International Access

The company has arranged toll-free international dial-in numbers to facilitate global investor participation:

• Singapore: 800 101 2045
• Hong Kong: 800 964 448
• USA: 1 866 746 2133
• UK: 0 808 101 1573

About Global Health Limited

Global Health Limited operates as one of the largest private multi-specialty tertiary care providers in North and East India. Founded by Dr. Naresh Trehan, a cardiovascular and cardiothoracic surgeon honored with Padma Bhushan and Padma Shri awards, the company has established a significant presence in the healthcare sector.

The company has four additional hospitals in various stages of planning or construction in Mumbai, New Delhi (Pitampura), South Delhi (GK), and Guwahati, with a planned bed capacity of approximately 2,000. Key specialties include cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.

Global Health Limited has received an ESG (Environmental, Social, and Governance) rating of 68 for Financial Year 2025 from SES ESG Research Private Limited. The healthcare company made this announcement through a regulatory filing on January 07, 2026, demonstrating its commitment to sustainable business practices and corporate governance standards.

ESG Rating Details

The ESG rating assessment was conducted by SES ESG Research Private Limited, a specialized firm that evaluates companies across environmental, social, and governance parameters. The rating of 68 indicates Global Health Limited's performance in key sustainability metrics for the financial year.

Regulatory Compliance

The company filed this information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, in accordance with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. This regulatory framework requires listed companies to disclose material information that could impact investor decisions.

Corporate Governance

The announcement was signed by Rahul Ranjan, Company Secretary & Compliance Officer (M. No. A17035), ensuring proper corporate governance protocols were followed. The digital signature was applied on January 07, 2026, at 17:19:57 +05'30', maintaining transparency in corporate communications.

Significance for Healthcare Sector

ESG ratings have become increasingly important for companies in the healthcare sector, as investors and stakeholders place greater emphasis on sustainable business practices. The rating reflects Global Health Limited's approach to environmental stewardship, social responsibility, and governance standards within the healthcare industry.